{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:39:47Z","timestamp":1767706787775,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Pharmacol"],"published-print":{"date-parts":[[2002,5,1]]},"DOI":"10.1124\/mol.61.5.1222","type":"journal-article","created":{"date-parts":[[2003,1,15]],"date-time":"2003-01-15T23:12:39Z","timestamp":1042672359000},"page":"1222-1234","source":"Crossref","is-referenced-by-count":128,"title":["The Nicotinic Allosteric Potentiating Ligand Galantamine Facilitates Synaptic Transmission in the Mammalian Central Nervous System"],"prefix":"10.1016","volume":"61","author":[{"given":"M\u00e1riton D.","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manickavasagom","family":"Alkondon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edna F. R.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasco","family":"Aracava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard M.","family":"Eisenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Maelicke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edson X.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2002,5,1]]},"reference":[{"key":"2019081414080668000_61.5.1222.1","doi-asserted-by":"crossref","unstructured":"Albuquerque EX Pereira EFR Alkondon M Eisenberg HM Maelicke A (2000a) Neuronal nicotinic receptors and synaptic transmission in the central nervous system. Handbook of Experimental Pharmacology (Clementi F, Gotti C and Fornasari D eds) pp 337\u2013358, Springer Verlag, New York.","DOI":"10.1007\/978-3-642-57079-7_13"},{"key":"2019081414080668000_61.5.1222.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(00)00208-4"},{"key":"2019081414080668000_61.5.1222.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00006-6"},{"key":"2019081414080668000_61.5.1222.4","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1523\/JNEUROSCI.19-07-02693.1999","article-title":"Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices.","volume":"19","author":"Alkondon","year":"1999","journal-title":"J Neurosci"},{"key":"2019081414080668000_61.5.1222.5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1523\/JNEUROSCI.20-01-00066.2000","article-title":"Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks.","volume":"20","author":"Alkondon","year":"2000","journal-title":"J Neurosci"},{"key":"2019081414080668000_61.5.1222.6","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(91)90005-V"},{"key":"2019081414080668000_61.5.1222.7","first-page":"728","article-title":"Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.","volume":"277","author":"Bores","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"2019081414080668000_61.5.1222.8","first-page":"589","article-title":"Methamidophos: an anticholinesterase without significant effects on postsynaptic receptors or transmitter release.","volume":"18","author":"Camara","year":"1997","journal-title":"Neurotoxicology"},{"key":"2019081414080668000_61.5.1222.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(05)70228-0"},{"key":"2019081414080668000_61.5.1222.10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.041600698"},{"key":"2019081414080668000_61.5.1222.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)01101-X"},{"key":"2019081414080668000_61.5.1222.12","doi-asserted-by":"publisher","DOI":"10.1126\/science.6338589"},{"key":"2019081414080668000_61.5.1222.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(96)00569-6"},{"key":"2019081414080668000_61.5.1222.14","unstructured":"Dempster J (1989) Microcomputers in physiology: a practical approach. in The Computer Analysis of Electrophysiological Data, ed Fraser PJ (Oxford, Oxford IRl Press), pp 51\u201393."},{"key":"2019081414080668000_61.5.1222.15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0079-6123(08)60453-7","article-title":"The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease.","volume":"116","author":"Farber","year":"1998","journal-title":"Prog Brain Res"},{"key":"2019081414080668000_61.5.1222.16","doi-asserted-by":"publisher","DOI":"10.1038\/78791"},{"key":"2019081414080668000_61.5.1222.17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02740634","article-title":"Nicotinic acetylcholine receptors in health and disease.","volume":"15","author":"Lindstrom","year":"1997","journal-title":"Mol Neurobiol"},{"key":"2019081414080668000_61.5.1222.18","doi-asserted-by":"publisher","DOI":"10.1016\/1359-6446(96)89089-1"},{"key":"2019081414080668000_61.5.1222.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0933-3657(98)00006-2"},{"key":"2019081414080668000_61.5.1222.20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00002826-198606000-00004","article-title":"GABA-agonist therapy for Alzheimer's disease.","volume":"9","author":"Mohr","year":"1986","journal-title":"Clin Neuropharmacol"},{"key":"2019081414080668000_61.5.1222.21","first-page":"S53","article-title":"PET studies and cholinergic therapy in Alzheimer's disease.","volume":"155","author":"Nordberg","year":"1999","journal-title":"Rev Neurol (Paris)"},{"key":"2019081414080668000_61.5.1222.22","doi-asserted-by":"publisher","DOI":"10.1358\/mf.2000.22.8.701373"},{"key":"2019081414080668000_61.5.1222.23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1432-1033.1991.tb16231.x","article-title":"A second pathway of activation of the Torpedo acetylcholine receptor channel.","volume":"200","author":"Okonjo","year":"1991","journal-title":"Eur J Biochem"},{"key":"2019081414080668000_61.5.1222.24","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(95)00490-4"},{"key":"2019081414080668000_61.5.1222.25","first-page":"768","article-title":"Physostigmine and galanthamine: probes for a novel binding site on the \u03b14\u03b22 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells.","volume":"270","author":"Pereira","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"2019081414080668000_61.5.1222.26","first-page":"1474","article-title":"Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.","volume":"265","author":"Pereira","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"2019081414080668000_61.5.1222.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00064-9"},{"key":"2019081414080668000_61.5.1222.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb11332.x"},{"key":"2019081414080668000_61.5.1222.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)01094-5"},{"key":"2019081414080668000_61.5.1222.30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1034\/j.1600-0404.2000.00310.x","article-title":"Galantamine is an allosterically potentiating ligand of the human \u03b14\u03b22 nAChR.","volume":"176","author":"Samochocki","year":"2000","journal-title":"Acta Neurol Scand Suppl"},{"key":"2019081414080668000_61.5.1222.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1993.tb18187.x"},{"key":"2019081414080668000_61.5.1222.32","first-page":"1","article-title":"Agonist responses of neuronal nicotinic receptors are potentiated by a novel class of allosterically acting ligands.","volume":"49","author":"Schrattenholz","year":"1996","journal-title":"Mol Pharmacol"},{"key":"2019081414080668000_61.5.1222.33","first-page":"527","article-title":"The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex.","volume":"28","author":"Shaw","year":"1985","journal-title":"Mol Pharmacol"},{"key":"2019081414080668000_61.5.1222.34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1523\/JNEUROSCI.21-03-00771.2001","article-title":"Synaptically driven calcium transients via nicotinic receptors on somatic spines.","volume":"21","author":"Shoop","year":"2001","journal-title":"J Neurosci"},{"key":"2019081414080668000_61.5.1222.35","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(95)00080-1"},{"key":"2019081414080668000_61.5.1222.36","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(89)90364-X"},{"key":"2019081414080668000_61.5.1222.37","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1212\/WNL.54.12.2269","article-title":"A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.","volume":"54","author":"Tariot","year":"2000","journal-title":"Neurology"},{"key":"2019081414080668000_61.5.1222.38","first-page":"121","article-title":"Drug receptors: considerations of their functional properties in disease and pharmacologic intervention.","volume":"1","author":"Taylor","year":"1982","journal-title":"Drug Ther"},{"key":"2019081414080668000_61.5.1222.39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.031584398"},{"key":"2019081414080668000_61.5.1222.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)80253-6"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.61.5.1222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T18:33:25Z","timestamp":1732732405000},"score":1,"resource":{"primary":{"URL":"http:\/\/molpharm.aspetjournals.org\/lookup\/doi\/10.1124\/mol.61.5.1222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,1]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2002,5,1]]},"published-print":{"date-parts":[[2002,5,1]]}},"alternative-id":["10.1124\/mol.61.5.1222"],"URL":"https:\/\/doi.org\/10.1124\/mol.61.5.1222","relation":{},"ISSN":["0026-895X","1521-0111"],"issn-type":[{"type":"print","value":"0026-895X"},{"type":"electronic","value":"1521-0111"}],"subject":[],"published":{"date-parts":[[2002,5,1]]}}}